ECM
CORT icon

Evergreen Capital Management’s Corcept Therapeutics CORT Stock Holding History

Evergreen Capital Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$374K Buy
9,266
+657
+8% +$24.6K 0.01% 980
2025
Q4 		$300K Buy
8,609
+248
+3% +$19.5K 0.01% 1038
2025
Q3 		$695K Buy
8,361
+755
+10% +$54.6K 0.02% 509
2025
Q2 		$558K Buy
7,606
+448
+6% +$32.5K 0.02% 515
2025
Q1 		$818K Buy
7,158
+265
+4% +$16.1K 0.03% 368
2024
Q4 		$347K Buy
6,893
+181
+3% +$9.48K 0.01% 663
2024
Q3 		$311K Buy
6,712
+48
+0.7% +$1.71K 0.01% 692
2024
Q2 		$217K Buy
+6,664
New +$183K 0.01% 819
2024
Q1 		– Sell
-6,651
Closed -$216K – 885
2023
Q4 		$216K Buy
+6,651
New +$183K 0.01% 746

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return